Title of Each Class of
Securities Offered
|
Maximum Aggregate
Offering Price |
Amount of
Registration Fee (1) |
||
HSBC USA Inc. Buffered Accelerated Market Participation SecuritiesTM linked to the S&P 500® Index due January 4, 2013
|
$1,000,000
|
$114.60
|
}
|
$1,000,000 Buffered AMPSTM linked to the S&P 500® Index
|
}
|
13-month maturity
|
}
|
2x exposure to any positive return in the reference asset, subject to a maximum return
|
}
|
Protection from the first 10% of any losses in the reference asset, subject to the credit risk of HSBC USA Inc.
|
Price to Public
|
Fees and Commissions1
|
Proceeds to Issuer
|
|
Per security
|
$1,000
|
$7.50
|
$992.50
|
Total
|
$1,000,000
|
$7,500
|
$992,500
|
HSBC USA Inc.
Buffered Accelerated Market Participation SecuritiesTM (AMPS)
|
![]() |
Issuer:
|
HSBC USA Inc.
|
Principal Amount:
|
$1,000 per security
|
Reference Asset
|
The S&P 500® Index (Ticker: SPX)
|
Pricing Date:
|
December 1, 2011
|
Trade Date:
|
December 1, 2011
|
Original Issue Date:
|
December 6, 2011
|
Final Valuation Date:
|
December 31, 2012. The Final Valuation Date is subject to adjustment as described under “Additional Terms of the Notes” in the accompanying underlying supplement.
|
Maturity Date:
|
3 business days after the Final Valuation Date, which is expected to be January 4, 2013. The Maturity Date is subject to adjustment as described under “Additional Terms of the Notes” in the accompanying underlying supplement.
|
Upside Participation Rate:
|
200%
|
Maximum Cap:
|
16.00%
|
Payment at Maturity:
|
On the Maturity Date, for each security, we will pay you the Final Settlement Value.
|
Final Settlement Value:
|
If the Reference Return is greater than zero, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount of securities, equal to the lesser of:
(a) $1,000 + ($1,000 × Reference Return × Upside Participation Rate); and
(b) $1,000 + ($1,000 × Maximum Cap).
If the Reference Return is less than or equal to zero but greater than or equal to the Buffer Level, you will receive $1,000 per $1,000 Principal Amount of securities (zero return).
If the Reference Return is less than the Buffer Level, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount of securities, calculated as follows:
$1,000 + [$1,000 × (Reference Return + 10%)].
Under these circumstances, you will lose 1% of the Principal Amount of your securities for each percentage point that the Reference Return is below the Buffer Level. For example, because the buffer protects the first 10% of loss, if the Reference Return is -30%, you will suffer a 20% loss and receive 80% of the Principal Amount. If the Reference Return is less than the Buffer Level, you may lose up to 90% of your investment.
|
Reference Return:
|
The quotient, expressed as a percentage, calculated as follows:
|
Final Level – Initial Level
Initial Level
|
|
Buffer Level:
|
-10%
|
Initial Level:
|
1,246.96, which was the Official Closing Level on November 30, 2011.
|
Final Level:
|
The Official Closing Level of the Reference Asset on the Final Valuation Date.
|
Official Closing Level:
|
The closing level of the Reference Asset on any scheduled trading day as determined by the calculation agent based upon the level displayed on Bloomberg Professional® service page “SPX <INDEX>”, or on any successor page on Bloomberg
|
Professional® service or any successor service, as applicable.
|
|
Form of securities:
|
Book-Entry
|
Listing:
|
The securities will not be listed on any U.S. securities exchange or quotation system.
|
CUSIP / ISIN:
|
4042K1UC5 / US4042K1UC52
|
}
|
The underlying supplement no. 3 at: http://www.sec.gov/Archives/edgar/data/83246/000114420410055205/v198039_424b2.htm
|
}
|
The product supplement at: http://www.sec.gov/Archives/edgar/data/83246/000114420409019791/v145840_424b2.htm
|
}
|
The prospectus supplement at: http://www.sec.gov/Archives/edgar/data/83246/000114420409019785/v145824_424b2.htm
|
}
|
}
|
You seek an investment with an enhanced return linked to the potential positive performance of the Reference Asset and you believe the level of the Reference Asset will increase over the term of the securities, but not by more than the Maximum Cap as leveraged by the Upside Participation Rate.
|
}
|
You are willing to invest in the securities based on the Maximum Cap indicated herein, which may limit your return at maturity.
|
}
|
You are willing to make an investment that is exposed to the negative Reference Return on a 1-to-1 basis for each percentage point that the Reference Return is less than -10%.
|
}
|
You are willing to forgo dividends or other distributions paid to holders of stocks comprising the Reference Asset.
|
}
|
You do not seek current income from your investment.
|
}
|
You do not seek an investment for which there is an active secondary market.
|
}
|
You are willing to hold the securities to maturity.
|
}
|
You are comfortable with the creditworthiness of HSBC, as issuer of the securities.
|
}
|
You believe the Reference Return will be negative or that the Reference Return will not be sufficiently positive to provide you with your desired return.
|
}
|
You are unwilling to invest in the securities based on the Maximum Cap indicated herein, which may limit your return at maturity.
|
}
|
You are unwilling to make an investment that is exposed to the negative Reference Return on a 1-to-1 basis for each percentage point that the Reference Return is below -10%.
|
}
|
You seek an investment that provides a full return of principal.
|
}
|
You prefer the lower risk, and therefore accept the potentially lower returns, of conventional debt securities with comparable maturities issued by HSBC or another issuer with a similar credit rating.
|
}
|
You prefer to receive the dividends or other distributions paid on any stocks comprising the Reference Asset.
|
}
|
You seek current income from your investment.
|
}
|
You seek an investment for which there will be an active secondary market.
|
}
|
You are unable or unwilling to hold the securities to maturity.
|
}
|
You are not willing or are unable to assume the credit risk associated with HSBC, as issuer of the securities.
|
}
|
“— Risks Relating to All Note Issuances” in the prospectus supplement; and
|
}
|
“— Additional Risks Relating to Notes with an Equity Security or Equity Index as the Reference Asset” in the prospectus supplement.
|
}
|
Principal Amount:
|
$1,000
|
}
|
Initial Level:
|
1,246.96
|
}
|
Upside Participation Rate:
|
200%
|
}
|
Maximum Cap:
|
16.00%
|
Hypothetical
Final Level
|
Hypothetical
Reference Return |
Hypothetical
Payment at Maturity
|
Hypothetical
Return on the Security
|
2,493.92
|
100.00%
|
$1,160.00
|
16.00%
|
2,244.53
|
80.00%
|
$1,160.00
|
16.00%
|
1,995.14
|
60.00%
|
$1,160.00
|
16.00%
|
1,745.74
|
40.00%
|
$1,160.00
|
16.00%
|
1,621.05
|
30.00%
|
$1,160.00
|
16.00%
|
1,496.35
|
20.00%
|
$1,160.00
|
16.00%
|
1,434.00
|
15.00%
|
$1,160.00
|
16.00%
|
1,371.66
|
10.00%
|
$1,160.00
|
16.00%
|
1,346.72
|
8.00%
|
$1,160.00
|
16.00%
|
1,309.31
|
5.00%
|
$1,100.00
|
10.00%
|
1,271.90
|
2.00%
|
$1,040.00
|
4.00%
|
1,259.43
|
1.00%
|
$1,020.00
|
2.00%
|
1,246.96
|
0.00%
|
$1,000.00
|
0.00%
|
1,234.49
|
-1.00%
|
$1,000.00
|
0.00%
|
1,222.02
|
-2.00%
|
$1,000.00
|
0.00%
|
1,184.61
|
-5.00%
|
$1,000.00
|
0.00%
|
1,122.26
|
-10.00%
|
$1,000.00
|
0.00%
|
1,059.92
|
-15.00%
|
$950.00
|
-5.00%
|
997.57
|
-20.00%
|
$900.00
|
-10.00%
|
872.87
|
-30.00%
|
$800.00
|
-20.00%
|
748.18
|
-40.00%
|
$700.00
|
-30.00%
|
498.78
|
-60.00%
|
$500.00
|
-50.00%
|
249.39
|
-80.00%
|
$300.00
|
-70.00%
|
0.00
|
-100.00%
|
$100.00
|
-90.00%
|
Reference Return:
|
2.00%
|
Final Settlement Value:
|
$1,040.00
|
Reference Return:
|
20.00%
|
Final Settlement Value:
|
$1,160.00
|
Reference Return:
|
-5.00%
|
Final Settlement Value:
|
$1,000.00
|
Reference Return:
|
-40.00%
|
Final Settlement Value:
|
$700.00
|
Description of the SPX
The SPX is a capitalization-weighted index of 500 U.S. stocks. It is designed to measure performance of the broad domestic economy through changes in the aggregate market value of 500 stocks representing all major industries.
The top 5 industry groups by market capitalization as of December 1, 2011 were: Information Technology, Financials, Energy, Health Care and Consumer Staples.
For more information about the SPX, see “The S&P 500Ò Index” on page US3-4 of the accompanying underlying supplement no. 3.
|
Historical Performance of the SPX
The following graph sets forth the historical performance of the SPX based on the daily historical closing levels from December 4, 2006 through December 1, 2011. The closing level for the SPX on December 1, 2011 was 1,244.58. We obtained the closing levels below from Bloomberg Professional® service. We make no representation or warranty as to the accuracy or completeness of the information obtained from Bloomberg Professional® service.
![]() |
TABLE OF CONTENTS
|
You should only rely on the information contained in this pricing supplement, any accompanying underlying supplement, product supplement, prospectus supplement and prospectus. We have not authorized anyone to provide you with information or to make any representation to you that is not contained in this pricing supplement, the accompanying underlying supplement, product supplement, prospectus supplement and prospectus. If anyone provides you with different or inconsistent information, you should not rely on it. This pricing supplement, the accompanying underlying supplement, product supplement, prospectus supplement and prospectus are not an offer to sell these securities, and these documents are not soliciting an offer to buy these securities, in any jurisdiction where the offer or sale is not permitted. You should not, under any circumstances, assume that the information in this pricing supplement, the accompanying underlying supplement, product supplement, prospectus supplement and prospectus is correct on any date after their respective dates.
HSBC USA Inc.
$1,000,000 Buffered Accelerated
Market Participation Securities Linked to the S&P 500® Index
December 1, 2011
PRICING SUPPLEMENT
|
||
Pricing Supplement
|
|||
General
|
PS-4
|
||
Payment at Maturity
|
PS-4
|
||
Investor Suitability
|
PS-5
|
||
Risk Factors
|
PS-6
|
||
Illustrative Examples
|
PS-8
|
||
The S&P 500® Index
|
PS-10
|
||
Supplemental Plan of Distribution (Conflicts of Interest)
|
PS-10
|
||
U.S. Federal Income Tax Considerations
|
PS-10
|
||
Underlying Supplement no. 3
|
|||
Risk Factors
|
US3-1
|
||
The S&P 500® Index
|
US3-4
|
||
The Russell 2000® Index
|
US3-8
|
||
The Dow Jones Industrial AverageSM
|
US3-11
|
||
The Hang Seng China Enterprises Index®
|
US3-13
|
||
The Hang Seng® Index
|
US3-15
|
||
The Korea Stock Price Index 200
|
US3-17
|
||
MSCI Indices
|
US3-20
|
||
The Dow Jones EURO STOXX 50® Index
|
US3-24
|
||
The PHLX Housing SectorSM Index
|
US3-26
|
||
The TOPIX® Index
|
US3-30
|
||
The NASDAQ-100 Index®
|
US3-33
|
||
S&P BRIC 40 Index
|
US3-37
|
||
The Nikkei 225 Index
|
US3-40
|
||
The FTSE™ 100 Index
|
US3-42
|
||
Other Components
|
US3-44
|
||
Additional Terms of the Notes
|
US3-44
|
||
Product Supplement
|
|||
Notice to Investors
|
PS-1
|
||
Product Supplement Summary
|
PS-1
|
||
Risk Factors
|
PS-4
|
||
Pricing Supplement Overview
|
PS-7
|
||
Valuation of the Notes
|
PS-7
|
||
Hypothetical Examples
|
PS-10
|
||
Specific Terms of the Notes
|
PS-19
|
||
Certain U.S. Federal Income Tax Considerations
|
PS-24
|
||
Events of Default and Acceleration
|
PS-25
|
||
Information Regarding the Reference Asset and Reference
Issuers |
PS-25
|
||
Certain ERISA Considerations
|
PS-25
|
||
Validity of the Notes
|
PS-25
|
||
Prospectus Supplement
|
|||
Risk Factors
|
S-3
|
||
Pricing Supplement
|
S-16
|
||
Description of Notes
|
S-16
|
||
Sponsors or Issuers and Reference Asset
|
S-37
|
||
Use of Proceeds and Hedging
|
S-37
|
||
Certain ERISA
|
S-38
|
||
Certain U.S. Federal Income Tax Considerations
|
S-39
|
||
Supplemental Plan of Distribution
|
S-52
|
||
Prospectus
|
|||
About this Prospectus
|
2
|
||
Special Note Regarding Forward-Looking Statements
|
2
|
||
HSBC USA Inc.
|
3
|
||
Use of Proceeds
|
3
|
||
Description of Debt Securities
|
4
|
||
Description of Preferred Stock
|
16
|
||
Description of Warrants
|
22
|
||
Description of Purchase Contracts
|
26
|
||
Description of Units
|
29
|
||
Book-Entry Procedures
|
32
|
||
Limitations on Issuances in Bearer Form
|
36
|
||
Certain U.S. Federal Income Tax Considerations Relating to
Debt Securities |
37
|
||
Plan of Distribution
|
52
|
||
Notice to Canadian Investors
|
54
|
||
Certain ERISA Matters
|
58
|
||
Where You Can Find More Information
|
59
|
||
Legal Opinions
|
59
|
||
Experts
|
59
|
D!\@'Z`@,"#`(4`AT")@(O`C@"
M00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@`NL"]0,``PL#%@,A
M`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#[`/Y!`8$$P0@!"T$
M.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#044%]@8&!A8&)P8W!D@&609J!GL&C`:=!J\&P`;1!N,&
M]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?"#((1@A:"&X(@@B6
M"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)^PH1"B<*/0I4"FH*
M@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY#!(,*@Q##%P,=0R.
M#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.20YD#G\.FPZV#M(.
M[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y$-<0]1$3$3$13Q%M
M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3@Q.D$\43Y10&%"<4
M211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86219L%H\6LA;6%OH7'1=!
M%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9MQG=&@0:*AI1&G<:
MGAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@\"$<(4@A=2&A( &YXS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA
M?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$'82`A..%1X6KA@Z&
M
D!\@'Z`@,"
M#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"U0+@
M`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3`^`#
M[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%#04<
M!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J!GL&
MC`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@("P@?
M"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/">4)
M^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+X0OY
M#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3#BX.
M20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0FQ"Y
M$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#$V,3
M@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86219L
M%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK&9$9
MMQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<]1T>
M'4<=:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8(,0@
M\"$<(4@A=2&A( &YXS'DJ>8EYYWI&>J5[!'MC
M>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7@[J$
M'82`A..%1X6KA@Z&
HRYU3&Z#V#U@[=5N_?;CY7O_`$?IU5V?::!5
M6XC[JQZ/2:*22;C-5ID6?IF`MLIVN=7_`#3_`$[?])?7C_T:Q?<3^_\`@K_E
M3'_Q,?\`PS_UV^8)+V/_`+%O^Z'_`("D?^:\:?8)[?S27W$_O_@K_E3'_P`3
M'_PS_P!=OCB2](&6?3.[!Z2;1630XOI:39M.]K\?U+&U;??L97FW^M_A+\7U
MO5QM/I[^D/QR>H5].JOWO`;6:BTL#CZ+N7>]U>W>E]Q/[_X)_P"5,?\`Q,?_
M``S_`-=ODB2]D_[&/^Z/_@2SL^[%KRV#`QNEWXY:W<;'U5G<7[;?TK?4=[*?
M=77]E?ZOZ3]/1Z5=>2ON)_?_``5_RIC_`.)C_P"&?^NWRQ)>H8]^.[*H%F/T
MJO# G)E4WI.5&-Z:V,Y9"<_/@H\>#IX;7!M971A('AM;&YS.G@]
M)V%D;V)E.FYS.FUE=&$O)R!X.GAM<'1K/2=835`@=&]O;&MI="`S+C`M,C@L
M(&9R86UE=V]R:R`Q+C8G/@H\ PC5OS$\VZIJ
M%AJ,]_(M[I]NMM#,C$5`))=@:J7DV]3^?CF'/4SD02=XO0Z;L32X<<\<8#@R
MRXY1_P![_5C_``?S7I^I?G';7GY4*D5[Z/FGU(Q-$"58M';;O
MS-Y4GO+TEKV.^N%G-*)65O7"QBK'@JR\5KF9H *'8J[%78J[%78JH27UE%,8))XTG6)IS$S`,(E-&DX]>`)^U@,AR;(X9D<
M0!X;X+_I_P`S^LP37/ST\@Z=8RS6MX-1NU`,=I"&JY)(IZG$HOV2?^NTS"R=
MH8HC8\1>ETGLAKLLP)1\*'\^?\/^9]7X_HR0WY5_F@WF#0M8U+7;F&&6RN)9
M1"M`8;-8ED%0-RJTD^,_;XX-'J^.),CR/^Q;?:+V?_*YL>/!&4ADA&/%_JF?
MCX/^(]/\+Q7\V/S#N/-WF&7ZM,QT*U)CT^+B4Y+MRE=3N2["J\OLIQ^!6YYJ
M=9J3EEM](^E]`]F^Q(Z'`.(?OY^K*?J_S(_U?]U_%+TIU^07FQM-\U1:1*Q2
MSODNC*Q;X`ZQ)*K$;?96W=?^>N6]G9N&?#T-_C_8NO\`;/LWQ=,<3%Q?JKEC&IKH#K,?
M<*VADQ;4UN[8!]%J;D^2?]V7Y,_*?[JY?_;8O_2D7S!)))8[Z.I))))2DDDD
ME*22224I))))2DDDDE*22224I))))2;#_I='_&,_ZH+W)>&X?]+H_P",9_U0
M7N2N\CM/Z/+?\:?GY;RR?]P__]3U5
UK
MQ^;[';UTRYE]F77EY)R<3!?3;D`O?=<&D.:[T\#]!8[)K9NJ8U_K,]&WUGVO
M_9_J5_K(D+B1W!'VK\,_;RX\E7[0!YJ'I0>OA[I'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$A
MSB'[(B3.>.4#4A2KA8.Q5__T/5#
MEPC%`&<`\58\03V!(#4^[%7G^N?F++IGDM-4OM5TG1=7:ZFMDCO`TEO*T5Q-
M"D2
RU6=>:QL`KG4ZL1YB0%4"QG&";>B
MKZZ;;&L;.I72=/>ZQH)7!8+@RX$KL.G=0K:P21PK$" -'(@L7/AQ:=#".S-N9R93>%5NWZB'?DMI87$Z]EGMZB(
M]P5;)R77N\&^"0BJV%USKGESN2H`0E"24DR=)2R222"E))))O5*DDDR
M)0NF23IJEDDDDE*2224RU=))))*R2=,@I2222*%))))*723))*722212I)).
MDA7=)+ND@I2=,D@E=),DDI22222ETDR22ETDR22ETDR22E)))%)2DD@DBI9)
M+LDDI<))!))2DD@DDI22222E)))(*4G3))*4G3))*4G3))*4G3))*4G3))*7
M23))*723))*4G3))*73)))*73)))*4DDDDI2=,DDI22222E))))*4DDDDI=,
MG3)*4DDDDI22222ETR=,DI22222E)TR=)2DDDDE*22224LG3)TE*3)))*722
M224I))))2DDDDE*22224I))))2DDDDE*22224I))))2DDDDE*22224I)))`J
M4DDDDI123%))2DZ9)%2DDDDDJ22*2"%DDDD%**9.4R;U2NDDF14NF2202I))
M)!3_`/_9#0IE;F1S=')E86T-96YD;V)J#3@W(#`@;V)J#3P\+T)I='-097)#
M;VUP;VYE;G0@."]#;VQO
MZ22ISE*6YMG``V63)TDRDJA)*$Z5*6A).DE2F/=*%(IH2I2R2>%)M9<8`E"E
M,0TE&IQ+;3#6DK1Z=T6Z]P):876=.Z)70T$M$I\86@RIYK!^K-]Y!L]K5J_\
MS\3;](SXKIF4-8(`A,^!HI.``+>(O"]3^K;\5N^HES5A/86DM.A"]*S?2>PL
M,+@>J5BO*>!Q*CE&EX+2A*$Z2;2EDD\)DJ4LG21\2CUKFL[%.C`D@#JHFF-.
M/;[FE+H/3'R"@>3.G@DE+?I=_P2
M4EM=%PDGA*`DA9)/"=)+%.G22I2T!.DE"-(4G"03IP4H)PDG"<`I2=).`G`(
M5"=).B%*22"=.`0I.E"2<$*223HJ622214I)))%2D@DDDI2=)))2Z29))2Z2
M222E))))*3XS]KPM_$NE@7--,&5K8-_MB4@LD'<;:$3U0`LT7)G7F$3`K&SD
M90'!67D99,ZIK[B51L?*85X"UMQ)Y0'.E)SD,E,7J)42D2HRDI1*9,2D2@E:
M4Z0:3QJB,H=R48QD=@HD(H)1&UGNB%@9YIMX2D!#?=0U7#0$Y<`@NN\$-UA*
MK9,U[+Q%*^U!<^5$F4E`22N4DDD@I=))).4NG23A$*4`I@)@I!/"UA22222ETR222E24TITDE+))))*723)TE*22"2
M2E)))()4F3IDE*22224I.F224I.F224I.F224I.F224NDF224NDF224NDDDD
MI22222E))))*4GE,DDA22=,DI142I%,?O0*6*;7XITH\#":4L3JF/!G0IR"3
MYI&8U35,#$:#XISQ!&BD`2))&G*B?O32E5;'/>U@UWF`NDII].MC&GVM`&OD
MLGI%&ZXVD2&$K9@'M'DJ?,SN0B/T?S=CX9BX8'(=Y[>05H#K\DO;X_%/!&
M@T2TY(54NBH#_4)1!U_!/!),)`..G`07+'Q//DFAHX,!2]H)U*:#,!OWI%(6
MCRDCOPFB1X%2(\2=>R>&DS$%!3".QT\TO*04^I)U!3D&-=/!%!I@9&G95L^\
M8^(\M/N?HT=Y5N'1_%8?6+B^_P!%ID5C7XE/PQXI@=-VOSN;VL$B#J?3'S+G
M@R?/NGW$>-6A(8V!W:$P\J.ZOO']5Y/:_@`E.VBYQT8?N76>C@-,
MA@4768[?HUA(4%+IPHIPDI=))))2DZ4)(A2X*D"HIT\*(9@J04`IM"EA&UI+(*8"9
MH4PK$8K"5TR=)/I"R4)TR2E))))*4F3I)*4F*=)!*R2222E))))*4DDDDI22
M222E))))*4DDDDI=,G224LDDDDI22=,DI22222E))))*4DDG24I))))2DDDD
ME*22224I))))2DWQ4DR"EM$R=,4"I13'3O!2/'FF^*:2E4^!3?C\$M)X3$F"
M."FVEDVVU@VM>YH\&DC\B?[9ECBZT?VG(W3L8W7;SJQFI\SX+:#&'EH/Q"@R
M9^`\(O1N
:%5X]6X=(@4C')/&\#K?$)%2>)&\CX&)IEJP!W*:U:W4AE0)-HC[;EGRF
MJ2Q2)>I5;:0.@0=K+Y$T9L[^X:\C\\_Q?8_\%A5+!_OW`I;$"9R@+2.(1>.,
MUB%HUD"KT"W"`M5B?VP`4)N3#.-"+)K`))ESZI9:52,):/9O67F3.3BP>I
MF(=GJ=*0.8EU11$>B2L>_RWQ(@NR@F7D(5LIP>V'BR!M<5NT4!W6K]5=T>MU
MH"=$%0S9*8_&'(SSS`1OC;5XR(ZK5G/W>I.`9%CAC.E:1#W#^Q4